{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:33:40Z","timestamp":1786991620710,"version":"build-2736575974"},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T00:00:00Z","timestamp":1730073600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007249","name":"University of Minnesota","doi-asserted-by":"publisher","award":["U24DK100469"],"award-info":[{"award-number":["U24DK100469"]}],"id":[{"id":"10.13039\/100007249","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007249","name":"University of Minnesota","doi-asserted-by":"publisher","award":["433 UL1TR000135"],"award-info":[{"award-number":["433 UL1TR000135"]}],"id":[{"id":"10.13039\/100007249","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR000114"],"award-info":[{"award-number":["UL1TR000114"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01 DK101402"],"award-info":[{"award-number":["R01 DK101402"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","cysticfibrosisjournal.com","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.jcf.2024.10.005","type":"journal-article","created":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T06:35:52Z","timestamp":1731047752000},"page":"57-65","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Exogenous insulin does not reduce protein catabolism in pre-diabetic cystic fibrosis patients: A randomized clinical trial"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0590-2399","authenticated-orcid":false,"given":"Michele","family":"Schiavon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Cobelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. Sreekumaran","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1461-5025","authenticated-orcid":false,"given":"Katherine","family":"Klaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6776-5230","authenticated-orcid":false,"given":"Gianna","family":"Toffolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2694-5147","authenticated-orcid":false,"given":"Antoinette","family":"Moran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcf.2024.10.005_bib0001","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.2337\/dc10-1768","article-title":"Clinical care guidelines for CFRD: recommendations from the cystic fibrosis foundation, the american diabetes association and the pediatric endocrine society","volume":"33","author":"Moran","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcf.2024.10.005_bib0002","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.2337\/dc10-1279","article-title":"Epidemiology, pathophysiology and prognstic implications of CFRD: a technical review","volume":"33","author":"Moran","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcf.2024.10.005_bib0003","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1164\/rccm.201403-0576OC","article-title":"Diabetes-related mortality in adults with cystic fibrosis. Role of genotype and sex","volume":"191","author":"Lewis","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2024.10.005_bib0004","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/pedi.13453","article-title":"ISPAD Clinical Practice Consensus Guidelines 2022: Management of cystic fibrosis-related diabetes in children and adolescents","volume":"23","author":"Ode","year":"2022","journal-title":"Pediatric Diabetes"},{"key":"10.1016\/j.jcf.2024.10.005_bib0005","first-page":"133","article-title":"Protein metabolism in diabetes mellitus","volume":"8","author":"Nair","year":"1995","journal-title":"Diab . Nutr. Metab."},{"key":"10.1016\/j.jcf.2024.10.005_bib0006","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1007\/BF01957574","article-title":"Influence of the development of diabetes mellitus on clinical status in patients with cystic fibrosis","volume":"151","author":"Lanng","year":"1992","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jcf.2024.10.005_bib0007","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1164\/ajrccm.162.3.9904075","article-title":"Trends in pulmonary function in cystic fibrosis patients correlate with the degree of glucose intolerance at baseline","volume":"162","author":"Milla","year":"2001","journal-title":"Am J Resp Crit Care Med"},{"key":"10.1016\/j.jcf.2024.10.005_bib0008","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.jpeds.2007.09.025","article-title":"Glucose tolerance and insulin secretion, morbidity and death in patients with CF","volume":"152","author":"Bismuth","year":"2008","journal-title":"J Pediatr"},{"key":"10.1016\/j.jcf.2024.10.005_bib0009","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1136\/thx.2010.142141","article-title":"Nocturnal hypoxemia and glucose tolerance in children with cystic fibrosis","volume":"66","author":"Suratwala","year":"2011","journal-title":"Thorax"},{"key":"10.1016\/j.jcf.2024.10.005_bib0010","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2337\/dc09-1492","article-title":"Early glucose abnormalities in cystic fibrosis are preceded by poor weight gain","volume":"33","author":"Hameed","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcf.2024.10.005_bib0011","doi-asserted-by":"crossref","first-page":"292","DOI":"10.2337\/dc10-1604","article-title":"Elevation of 1-hour plasma glucose during oral glucose tolerance testing is associated with worse pulmonary function in cystic fibrosis","volume":"34","author":"Brodsky","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcf.2024.10.005_bib0012","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.2337\/diabetes.50.6.1336","article-title":"Protein metabolism in clinically stable adult CF patients with abnormal glucose tolerance","volume":"50","author":"Moran","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.jcf.2024.10.005_bib0013","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1542\/peds.101.3.433","article-title":"Proteolysis associated with insulin resistance in cystic fibrosis","volume":"101","author":"Hardin","year":"1998","journal-title":"Pediatrics"},{"key":"10.1016\/j.jcf.2024.10.005_bib0014","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1399-5448.2008.00451.x","article-title":"One year glargine treatment can improve the course of lung disease in children and adolescents with cystic fibrosis and early glucose derangements","volume":"10","author":"Mozzillo","year":"2009","journal-title":"Pediatric Diabetes"},{"key":"10.1016\/j.jcf.2024.10.005_bib0015","doi-asserted-by":"crossref","first-page":"RC1","DOI":"10.1007\/BF03345538","article-title":"Clinical effects of early treatment with insulin glargine in patients with cystic fibrosis and impaired glucose tolerance","volume":"29","author":"Bizzarri","year":"2006","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.jcf.2024.10.005_bib0016","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1136\/adc.87.5.430","article-title":"Clinical improvement in cystic fibrosis with early insulin treatment","volume":"87","author":"Dobson","year":"2002","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jcf.2024.10.005_bib0017","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/ppul.21495","article-title":"Cystic fibrosis related diabetes\u2013the end stage of progressive insulin deficiency","volume":"46","author":"Hameed","year":"2011","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2024.10.005_bib0018","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1399-5448.2011.00810.x","article-title":"Slow-release insulin in cystic fibrosis patients with glucose intolerance: a randomized clinical trial","volume":"13","author":"Minicucci","year":"2012","journal-title":"Pediatric Diabetes"},{"key":"10.1016\/j.jcf.2024.10.005_bib0019","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1515\/jpem.2011.050","article-title":"Low-dose insulin therapy in patients with cystic fibrosis and early-stage insulinopenia prevents deterioration of lung function: a 30 year prospective study","volume":"24","author":"Kolouskova","year":"2011","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.jcf.2024.10.005_bib0020","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/pedi.12014","article-title":"Exogenous insulin requirements do not differ between youth and adults with cystic fibrosis related diabetes","volume":"14","author":"Sunni","year":"2013","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.jcf.2024.10.005_bib0021","doi-asserted-by":"crossref","first-page":"E69","DOI":"10.1152\/ajpendo.00012.2018","article-title":"A novel triple-tracer appraoch to assess postprandial protein turnover","volume":"315","author":"Moran","year":"2018","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.jcf.2024.10.005_bib0022","first-page":"e41697","article-title":"The effects of elexacaftor, tezacaftor and ivacaftor (ETI) on blood glucose in patients with cystic fibrosis: a systematic review","volume":"15","author":"Salazar-Barragan","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.jcf.2024.10.005_bib0023","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jcf.2011.11.001","article-title":"Reduced levels of active GLP-1 in patients with cystic fibrosis with and without diabetes mellitus","volume":"11","author":"Hillmann","year":"2012","journal-title":"J Cyst Fib"},{"key":"10.1016\/j.jcf.2024.10.005_bib0024","doi-asserted-by":"crossref","first-page":"E851","DOI":"10.1210\/jc.2010-2460","article-title":"Gastric emptying, incretin hormone secretion, and postprandial glycemia in cystic fibrosis\u2013effects of pancreatic enzyme supplementation","volume":"96","author":"Kuo","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jcf.2024.10.005_bib0025","first-page":"271","article-title":"Ondansetron reduces nausea induced by gastroduodenal stimulation without changing gastric motility","author":"Feinle","year":"1996","journal-title":"Am J Phyiol"},{"key":"10.1016\/j.jcf.2024.10.005_bib0026","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.2337\/dc09-0585","article-title":"Insulin therapy to improve BMI in cystic fibrosis related diabetes without fasting hyperglycemia: Results of the Cystic Fibrosis Related Diabetes Therapy trial","volume":"32","author":"Moran","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcf.2024.10.005_bib0027","unstructured":"CFTR2: Clinical and Functional Translation of CFTR. https:\/\/www.cftr2.org (a collaboration of the Cystic Fibrosis Foundation and Johns Hopkins Medicine)."}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199324018009?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199324018009?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T17:11:43Z","timestamp":1738257103000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199324018009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S1569199324018009"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2024.10.005","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exogenous insulin does not reduce protein catabolism in pre-diabetic cystic fibrosis patients: A randomized clinical trial","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2024.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V. on behalf of European Cystic Fibrosis Society.","name":"copyright","label":"Copyright"}]}}